Evidence map›Paper›PMID 42669723›Full record

ReviewEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Glass ionomer cement in incudostapedial rebridging ossiculoplasty: A systematic review and meta-analysis.

Christos Tsilivigkos, Nikolaos Sakellaris, Evangelos N Vitkos, Marios Stavrakas

Abstract readReview
PubMed Publisher
In one paragraph

Review in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christos TsilivigkosFirst Department of Otolaryngology, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, 15772, Greece. tsilivig@med.uoa.gr.ORCID http://orcid.org/0000-0002-6113-9490
Nikolaos SakellarisDepartment of Otolaryngology, 'Gennimatas' General Hospital, Athens, 11527, Greece.
Evangelos N VitkosDepartment of Oral and Maxillofacial Surgery, Klinikum Dortmund, Dortmund, Germany.
Marios StavrakasENT Department, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the hearing outcomes and surgical success of glass ionomer cement (GIC) in incudostapedial rebridging ossiculoplasty (ISRO) in patients with different middle ear pathologies.

methodsA systematic literature review was conducted on Medline (via PubMed), the Cochrane Database, and Scopus from database inception to July 4, 2025. Two independent authors reviewed selected studies assessing the short-, middle-, or long-term tone audiometry results, the air-bone gap (ABG) closure percentage, and cement failure outcomes. The review adhered to the PRISMA reporting standards. Meta-analysis calculated the mean differences between post- and pre-operative pure-tone audiometry values (pooled estimates and 95% confidence intervals). ABG closure was analyzed with a meta-analysis of proportions applying a logit transformation.

resultsTwenty-four studies (17 observational cohort and 8 observational case-series) were included in this review, encompassing 749 patients receiving ISRO. All studies included provided preoperative and postoperative hearing outcomes. Nineteen studies reported outcomes regarding ABG closure < 20 dB, 10 regarding closure < 10 dB, 7 regarding cement failure, and 8 regarding postoperative adverse events following ISRO. A pooled mean change in ABG values of - 16.54 dB (95% CI - 20.61 to - 12.47) and in air conduction values of - 18.01 dB (95% CI - 20.86 to - 15.17) was achieved from pre- to post-operative middle-term outcomes. The pooled success rate was 77.3% for ABG < 20 dB (95% CI 71.9-82.0), and 52.7% (95% CI 41.3-63.8) for ABG < 10 dB.

conclusionIncudostapedial rebridging ossiculoplasty (ISRO) appears to be a reliable solution with good hearing outcomes 1 to 3 years postoperatively.

Indexed as

Chronic otitis mediaGlass ionomer cementIncudostapedial Rebridging OssiculoplastyOssicular chainOssiculoplastyTympanoplasty

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.